News from the FDA/CDC
News from the FDA/CDC
Children and COVID: Weekly cases maintain a low-level plateau
White House coordinator says that a holiday COVID-19 surge is unlikely.
News from the FDA/CDC
FDA approves first-ever agent to delay type 1 diabetes onset
Teplizumab delayed progression to clinical type 1 diabetes by about 2 years compared with placebo in individuals destined to develop the condition...
News from the FDA/CDC
Children and COVID: Weekly cases continue to hold fairly steady
The latest hospital admission data may be telling a somewhat different story.
News from the FDA/CDC
Children and COVID: New cases increase for second straight week
Extended declines in ED visits and hospitalizations may be reversing.
News from the FDA/CDC
CDC warns of early uptick in respiratory disease
As influenza viruses, respiratory syncytial virus, SARS-CoV-2, and rhinovirus/enterovirus simultaneously circulate, the agency cautioned that this...
News from the FDA/CDC
FDA expands tenofovir alafenamide (Vemlidy) use to adolescents with chronic HBV
The study met its primary endpoint of percentage of patients with HBV DNA levels less than 20 IU/mL at 24 weeks of therapy.
News from the FDA/CDC
Mid-October flulike illness cases higher than past 5 years
The 2022-2023 season is already “gathering speed … about a month early,” one expert said.
News from the FDA/CDC
Children and COVID: Weekly cases can’t sustain downward trend
Hospitalizations and emergency department visits may be on the rise again.
News from the FDA/CDC
Children and COVID: Weekly cases fall to lowest level in over a year
Reported new cases have dropped by almost 75% since the beginning of September.
News from the FDA/CDC
FDA approves upadacitinib (Rinvoq) for sixth indication
Upadacitinib’s approval for nonradiographic axial spondyloarthritis marks the sixth indication in the United States for the Janus kinase inhibitor...
News from the FDA/CDC
People of color more likely to be hospitalized for influenza, CDC report finds
“We must acknowledge that inequities in access to care continue to exist.”